Faculty

Janey Wiggs

Joint effort targets genes and traits to improve glaucoma screening, prevention and treatment

September 29, 2016

NIH and India fund collaborative grant for glaucoma research

Boston, Mass. —  Researchers from the U.S. and India have begun a new collaborative project to identify genetic risk factors and traits related to glaucoma, a leading cause of blindness worldwide. Funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), and India’s Department of Biotechnology (DBT), the researchers’ goal is to help develop effective screening, prevention, and treatment strategies for glaucoma. Grants from the two agencies...

Read more about Joint effort targets genes and traits to improve glaucoma screening, prevention and treatment
Lubricin data demonstrates significant improvement in multiple signs and symptoms of dry eye disease compared to sodium hyaluronate

Lubricin data demonstrates significant improvement in multiple signs and symptoms of dry eye disease compared to sodium hyaluronate

michael gilmore

Mass. Eye and Ear team discovers, successfully treats new variant of antibiotic-resistant bacterium

September 15, 2016

Boston, Mass. —  Researchers at Massachusetts Eye and Ear have discovered a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the body’s own immune system by inhibiting white blood cells that ordinarily kill and remove bacteria. In a paper published online today in JAMA Ophthalmology, the researchers describe the case that led them to...

Read more about Mass. Eye and Ear team discovers, successfully treats new variant of antibiotic-resistant bacterium
Researchers find proliferating cells in normal and diseased corneal endothelium

Researchers find proliferating cells in normal and diseased corneal endothelium

September 14, 2016

Findings published in the American Journal of Pathology offer new directions for treatment of patients with Fuchs’ Endothelial Corneal Dystrophy (FECD)

Boston, Mass. —  Researchers from Massachusetts Eye and Ear have, for the first time, identified rapidly proliferating cells (known as “neural crest-derived progenitor cells”) in the corneal endothelium of specimens from normal corneas and from corneas with Fuchs’ Endothelial Corneal Dystrophy (FECD), a condition in which the cells responsible for keeping the cornea...

Read more about Researchers find proliferating cells in normal and diseased corneal endothelium
Luk Vandenberghe

Lonza to Offer Novel Anc-AAV Gene Therapy Technology Through Exclusive Licensing Agreement with Massachusetts Eye and Ear

September 12, 2016
  • The strategic licensing agreement between Lonza and Massachusetts Eye and Ear® underscores Lonza’s position as a leading AAV manufacturing service provider and offers customers unprecedented technology and services to commercialize next generation gene therapies.
  • The Anc-AAV vector platform has the potential to overcome pre-existing immunity in order to treat more patients compared with other viral vectors currently in development.
  • Anc80, the lead novel Anc-AAV available for sublicensing, is a potent gene therapy vector capable of superior gene expression levels in...
Read more about Lonza to Offer Novel Anc-AAV Gene Therapy Technology Through Exclusive Licensing Agreement with Massachusetts Eye and Ear
Jospeh Ciolino, MD, with Drug Dispensing Contact Lens

Drug-dispensing contact lens effectively lowers eye pressure in pre-clinical glaucoma model

October 26, 2016

A contact lens designed to deliver medication gradually to the eye may improve outcomes for patients who struggle with imprecise, difficult to self-administer eye drops

Boston, Mass. — A contact lens designed to deliver medication gradually to the eye could improve outcomes for patients with conditions requiring treatment with eye drops, which are often imprecise and difficult to self-administer. In...

Read more about Drug-dispensing contact lens effectively lowers eye pressure in pre-clinical glaucoma model
Dr. Reza Dana to Receive 2016 Endre A. Balazs Prize

Dr. Reza Dana to Receive 2016 Endre A. Balazs Prize

April 28, 2016

Reza Dana, MD, MSc, MPH, Claes H. Dohlman Professor of Ophthalmology at Harvard Medical School, will receive the 2016 Endre A. Balazs Prize and present a Plenary Lecture at the XXII Biennial Meeting of International Society for Eye Research (ISER). The event will take place in Tokyo, Japan, on September 25 to 29, 2016. This prize honors a distinguished scientist whose outstanding contributions lead to significant progress in the field of experimental eye research. Past Harvard Ophthalmology recipients include...

Read more about Dr. Reza Dana to Receive 2016 Endre A. Balazs Prize
Dr. Jennifer Sun, Investigator in the Section of Vascular Biology, Receives Physician-Scientist Award from Research to Prevent Blindness

Dr. Jennifer Sun, Investigator in the Section of Vascular Biology, Receives Physician-Scientist Award from Research to Prevent Blindness

July 15, 2016

BOSTON – (July 15, 2016) – Jennifer K. Sun, MD, MPH, Investigator in the Section on Vascular Biology at Joslin Diabetes Center, an Ophthalmologist in Beetham Eye Institute (BEI) at Joslin Diabetes Center, and Associate Professor at Harvard Medical School, has been granted an Physician-Scientist Award by Research to Prevent Blindness (RPB). Up to $300,000 will be...

Read more about Dr. Jennifer Sun, Investigator in the Section of Vascular Biology, Receives Physician-Scientist Award from Research to Prevent Blindness
Lotfi Merabet

Lotfi B. Merabet, PhD, OD, Receives Low Vision Research Award

June 23, 2016

Boston, Mass. —  Lotfi B. Merabet, PhD, OD, MPH, an optometrist and vision researcher at Massachusetts Eye and Ear and an Associate Professor of Ophthalmology at Harvard Medical School, is the 2016 recipient of the Low Vision Research Award from Research to Prevent Blindness (RPB) and the Lions Clubs International Foundation (LCIF). Dr. Merabet will receive $300,000 over three years for...

Read more about Lotfi B. Merabet, PhD, OD, Receives Low Vision Research Award

Honors and Awards Received in May 2016

June 13, 2016

Patricia D'Amore, PhD, MBA, was the inaugural honoree of the Distinguished Alumna Award at Matignon High School's (Cambridge, MA) second annual Tradition of Excellence Gala. This award recognizes alumni who have made a mark in their field.

Darlene Dartt, PhD, received a grant from the National Eye Institute in the amount of $1,041,079 over five years for her project, Lacrimal gland repair using progenitor cells." This award will be split with...

Read more about Honors and Awards Received in May 2016
Luk Vandenberghe

Selecta Biosciences obtains exclusive license to proprietary gene therapy vector from Massachusetts Eye and Ear

May 19, 2016

Selecta is licensing Anc80 from Massachusetts Eye and Ear for a rare genetic disease with options on additional pre-specified indications. By combining Anc80 with Selecta’s investigational drug candidate, SVP-Rapamycin (SEL-110), Selecta is seeking to advance a new gene therapy platform designed to avoid several immunogenicity challenges that limit the development of gene therapies today 

Watertown, Mass. — Selecta Biosciences, Inc., a clinical-stage biopharmaceutical...

Read more about Selecta Biosciences obtains exclusive license to proprietary gene therapy vector from Massachusetts Eye and Ear

Pages